top of page
Browse by category
Search
Popularity of GLP-1s among privately insured patients may worsen disparities
Publicly insured US individuals who are most likely to benefit from new drugs for diabetes and obesity are less likely to get them than...
Price of anti-obesity medication fuels public health disparities
Millions of Black and Hispanic adults who are living with overweight or obesity are unable to afford the latest treatment in obesity...
Browse by tag
bottom of page